Clinical Trials Browser

Phase 2 × INDUSTRY × ADI PEG20 × Clear all

NCT04587830 2025-08-26

GBM

Phase 2 Active not recruiting

Glioblastoma

NCT01910012 2020-10-01

PH 2 ADI-PEG 20 Acute Myeloid Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01910025 2018-09-18

PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT02006030 2018-09-04

TACE

Phase 2 Completed

Gastrointestinal

Liver Neoplasms